Publications by authors named "Britney A Stottlemyer"

Claim this Profile
R
Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review.
Wafa Alatawi, Jessica L Wallace, Dhakrit Rungkitwattanakul, Britney A Stottlemyer, Tiffany L Tran

Clin Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Acute Kidney Injury with Nephrotoxic Burden in Non-Critical Patients: An Internal and External Validation Study.
Esra Adiyeke, Yuanfang Ren, Benjamin Shickel, Matthew M Ruppert, Ziyuan Guan, Britney A Stottlemyer

Kidney360· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-hospital electronic decision support for drug-associated acute kidney injury (MEnD-AKI): Study protocol for a randomized clinical trial.
Britney A Stottlemyer, John A Kellum, Azra Bihorac, Tezcan Ozrazgat-Baslanti, Raghavan Murugan

Contemp Clin Trials· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of the Costs of Drug-Associated Acute Kidney Injury and Potential Cost Savings With Nephrotoxin Stewardship Prevention Strategies.
Britney A Stottlemyer, Tiffany Tran, Kangho Suh, Sandra L Kane-Gill

Clin Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug-Associated Acute Kidney Injury in Retrospective, Observational Studies.
Nabihah Amatullah, Britney A Stottlemyer, Isabelle Zerfas, Cole Stevens, Tezcan Ozrazgat-Baslanti

Nephron· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method.
Britney A Stottlemyer, Kaleab Z Abebe, Paul M Palevsky, Linda Fried, Ivonne H Schulman

Drug Saf· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.
Britney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, Matthew P Gray, Richard D Boyce

Ther Adv Drug Saf· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Niti M Patel, Britney A Stottlemyer, Matthew P Gray, Richard D Boyce, Sandra L Kane-Gill

Cardiovasc Drugs Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database.
Hyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, Britney A Stottlemyer, Richard D Boyce

Respir Care· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017.
Mark Bounthavong, Kangho Suh, Meng Li, Patrick M Spoutz, Britney Ann Stottlemyer

Subst Abuse Treat Prev Policy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis